Memories.ai | $8,000,000 | (Jul 25, 2025)
Lyra (YC X25) | $6,000,000 | (Jul 25, 2025)
Maro | $4,300,000 | (Jul 25, 2025)
Certified by Founder
Lodge
DalCor Pharmaceuticals
start up
Canada
- Montreal, Québec
- 22/09/2023
- Series D
- $80,000,000
DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.
- Industry Biotechnology Research
- Website https://dalcorpharma.com/
- LinkedIn https://www.linkedin.com/company/dalcor-pharmaceuticals/about/
STELLARIA 🌀 | $23,000,000 | (Jul 25, 2025)
LegalOn Technologies | $50,000,000 | (Jul 25, 2025)
Bloom | $1,600,000 | (Jul 25, 2025)
Baxter Aerospace | $6,000,000 | (Jul 25, 2025)
Flend | $3,000,000 | (Jul 25, 2025)
Cascade Space | $5,900,000 | (Jul 25, 2025)
Scopio Labs | $10,000,000 | (Jul 25, 2025)
ArcSpan | $5,200,000 | (Jul 24, 2025)
Dispatch Bio | Undisclosed Amount | (Jul 24, 2025)